Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
24.20
-0.10 (-0.41%)
At close: Jan 30, 2026

TLV:TKUN Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
34.9544.2349.337.0321.66
34.9544.2349.337.0321.66
Revenue Growth (YoY)
-20.97%-10.28%33.13%70.97%-
Cost of Revenue
29.5332.731.1929.387.37
Gross Profit
5.4311.5318.117.6514.29
Selling, General & Admin
12.6222.8223.9527.6628.86
Research & Development
0.833.895.167.22.16
Other Operating Expenses
-0.12-0.64-0.330.855.07
Operating Expenses
19.9839.3644.4550.746.48
Operating Income
-14.55-27.83-26.34-43.05-32.2
Interest Expense
-1.88-2.3-1.77-1.28-1.19
Interest & Investment Income
-0.130.090.010.05
Earnings From Equity Investments
--0.38---
EBT Excluding Unusual Items
-16.44-30.38-28.02-44.32-33.33
Impairment of Goodwill
-22.34-59.63-17.57--
Gain (Loss) on Sale of Investments
-4.73-0.431.93--
Gain (Loss) on Sale of Assets
-----0.13
Asset Writedown
---15.27--
Legal Settlements
-----1.35
Other Unusual Items
3.4-3.569.7910.29-0.21
Pretax Income
-40.1-93.99-49.14-34.03-35.02
Income Tax Expense
-0.030.01--0.27
Earnings From Continuing Operations
-40.1-94.02-49.15-34.03-34.75
Minority Interest in Earnings
05.130.911.381.81
Net Income
-40.1-88.89-48.24-32.65-32.94
Net Income to Common
-40.1-88.89-48.24-32.65-32.94
Shares Outstanding (Basic)
8463494234
Shares Outstanding (Diluted)
8463494234
Shares Change (YoY)
32.86%29.54%15.79%23.01%86.23%
EPS (Basic)
-0.48-1.41-0.99-0.78-0.96
EPS (Diluted)
-0.48-1.41-0.99-0.78-0.96
Free Cash Flow
-3.78-4.12-23.2-33.49-50.69
Free Cash Flow Per Share
-0.04-0.07-0.48-0.80-1.48
Gross Margin
15.52%26.06%36.73%20.66%65.96%
Operating Margin
-41.63%-62.93%-53.44%-116.25%-148.65%
Profit Margin
-114.73%-200.97%-97.85%-88.17%-152.09%
Free Cash Flow Margin
-10.82%-9.31%-47.07%-90.43%-234.05%
EBITDA
14.2227.569.2-25.89-19.89
EBITDA Margin
40.69%62.32%18.66%-69.92%-91.84%
D&A For EBITDA
28.7755.3935.5417.1512.3
EBIT
-14.55-27.83-26.34-43.05-32.2
EBIT Margin
-41.63%-62.93%-53.44%-116.25%-148.65%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.